Cargando…
Early Detection of Cerebral Glucose Uptake Changes in the 5XFAD Mouse
Brain glucose hypometabolism has been observed in Alzheimer’s disease (AD) patients, and is detected with (18)F radiolabelled glucose, using positron emission tomography. A pathological hallmark of AD is deposition of brain β-amyloid plaques that may influence cerebral glucose metabolism. The five t...
Autores principales: | I.R, Macdonald, D.R, DeBay, G.A, Reid, T.P, O’Leary, C.T, Jollymore, G, Mawko, S, Burrell, E, Martin, C.V, Bowen, R.E, Brown, S, Darvesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082185/ https://www.ncbi.nlm.nih.gov/pubmed/24801216 http://dx.doi.org/10.2174/1567205011666140505111354 |
Ejemplares similares
-
No difference in cerebral perfusion between the wild-type and the 5XFAD mouse model of Alzheimer’s disease
por: DeBay, Drew R., et al.
Publicado: (2022) -
Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease
por: DeBay, Drew R., et al.
Publicado: (2017) -
Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer’s Disease
por: Macdonald, Ian R., et al.
Publicado: (2017) -
Visuo‐spatial learning and memory impairments in the 5xFAD mouse model of Alzheimer's disease: Effects of age, sex, albinism, and motor impairments
por: O'Leary, Timothy P., et al.
Publicado: (2022) -
NEMA NU 1-2018 performance characterization and Monte Carlo model validation of the Cubresa Spark SiPM-based preclinical SPECT scanner
por: Strugari, Matthew E., et al.
Publicado: (2023)